Jgp Global Gestao De Recursos Ltda. Summit Therapeutics Inc. Transaction History
Jgp Global Gestao De Recursos Ltda.
- $190 Million
- Q2 2025
A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 15,366 shares of SMMT stock, worth $440,389. This represents 0.17% of its overall portfolio holdings.
Number of Shares
15,366
Previous 15,366
-0.0%
Holding current value
$440,389
Previous $296,000
10.14%
% of portfolio
0.17%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
246Shares Held
87.3MCall Options Held
1.77MPut Options Held
2.49M-
Baker Bros. Advisors LP New York, NY24.4MShares$700 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$334 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$226 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$188 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$139 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.77B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...